Xeris Pharmaceuticals | XERS - Stock



Xeris Pharmaceuticals reported $67.28M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
Adcock Ingram Holdings ZAR 2.54B 136.46M Jun/2024
Celltrion KRW 2.83T 2.73T Mar/2025
Cspc Pharmaceutical CNY 3.13B 328.77M Dec/2024
Divis Laboratories Ltd 32.36B 910M Mar/2025
Eli Lilly USD 11.01B 1.7B Jun/2025
Kangmei Pharma 2.89B 80.05M Sep/2024
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Laboratorios Farma 327.67M 2.28M Jun/2025
Medical Developments International AUD 8.77M 729K Jun/2024
Organigram Holdings CAD 125.19M 21.23M Jun/2025
Pacira USD 148.16M 14.41M Jun/2025
Perrigo USD 1.22B 60.5M Jun/2025
Pharma Mar 49.5M 1.02M Jun/2025
Qiagen NV USD 292.55M 11.19M Jun/2025
Sartorius EUR 797.4M 9.5M Jun/2025
Sino Biopharmaceutical CNY 1.84B 156.17M Jun/2024
Supernus Pharmaceuticals USD 44.02M 5.4M Jun/2025
Tilray USD 266.01M 1.71M Nov/2024
Zz Pientze Pharmaceu 4.95B 21.49M Mar/2025